Expression Levels of RISC and Microprocessor Complex Components in Epithelial Skin Cancer
NCT01345760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2012-10-16
Summary
MicroRNAs (miRNAs) are very small endogenous RNA molecules about 22-25 nucleotides in length, capable of post-transcriptional gene regulation. miRNAs bind to their target messenger RNAs (mRNAs), leading to cleavage or suppression of target mRNA translation based on the degree of complementarity. miRNAs have recently been shown to play pivotal roles in diverse developmental and cellular processes and linked to a variety of skin diseases and cancers. In the present study, the investigators examines the expression profiles of the microprocessor complex subunit DGCR8 and the RISC components TARBP1, TARBP2, argonaute-1, argonaute-2 and PACT in epithelial skin cancer and its premalignant stage.
Conditions
Sponsors & Collaborators
-
Ruhr University of Bochum
lead OTHER
Principal Investigators
-
Falk G Bechara, PD Dr. · Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2011-02-28
- Completion
- 2011-02-28
Countries
- Germany
Study Locations
More Related Trials
-
Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma
NCT01143311 ·Status: TERMINATED ·Phase: NA
-
Expressiona and Diagnostic Potential of miRNAs in NSCLC
NCT05815407 ·Status: COMPLETED
-
Molecular Characterization of Cutaneous Tumors
NCT03092830 ·Status: UNKNOWN
-
microRNA Expression in Renal Cell Carcinoma
NCT00743054 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Patients With Rhabdomyosarcoma
NCT01433237 ·Status: COMPLETED
-
Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics
NCT06476964 ·Status: RECRUITING ·Phase: NA
-
"Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"
NCT06759714 ·Status: RECRUITING
-
Profiling and Targeting Epigenetic Marks to Improve Diagnosis and Therapeutic Approaches in Head and Neck Cancer
NCT06706973 ·Status: RECRUITING
-
Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy
NCT01265472 ·Status: UNKNOWN
-
Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
NCT02199938 ·Status: TERMINATED
-
Different Genetic Features Associated With Hepatic Carcinogenesis
NCT01247506 ·Status: UNKNOWN
-
Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform
NCT06868927 ·Status: RECRUITING
-
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
NCT01365962 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
NCT01209299 ·Status: COMPLETED
-
Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma
NCT05550766 ·Status: UNKNOWN
-
Strata EXPress™: A Study Using StrataEXP™ to Identify RNA-Expression Biomarkers in Advanced Cancer Patients
NCT05312307 ·Status: WITHDRAWN
-
UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS: a MULTI -OMICS PLATFORM for IMPROVED PATIENTS MANAGEMENT
NCT06582108 ·Status: NOT_YET_RECRUITING
-
Tissue Microarrays (TMAs) Construction in Lung Cancer Samples
NCT03136523 ·Status: COMPLETED
-
Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma
NCT03167476 ·Status: UNKNOWN
-
Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer
NCT00876408 ·Status: COMPLETED
-
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
NCT02253251 ·Status: RECRUITING
-
Study to Examine Lesions of the Skin Using Confocal Laser Microscopy
NCT06598137 ·Status: ACTIVE_NOT_RECRUITING
-
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
NCT03265496 ·Status: TERMINATED ·Phase: NA
-
Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma
NCT06777082 ·Status: RECRUITING
-
Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit
NCT05347797 ·Status: COMPLETED ·Phase: NA